Filing Flows › Industries › Health Care › Electromedical & Electrotherapeutic Apparatus
Electromedical & Electrotherapeutic Apparatus SIC 3845
25 companies filing with the SEC under SIC 3845. Median revenue growth +12% year on year in Q2 2026 (middle half -3% to +33%, 25 companies). The growth model expects the industry's combined revenue to grow +10% in Q3 2026. 4 customer or supplier links named in annual reports.
Money flow: where the industry's revenue goes
Drawn in the browser: an estimate of where the industry's revenue goes — what it buys from other industries, the pay that reaches households, taxes and profit — beside its filed cash flow, two tiers of suppliers and its capital spending by kind of asset.
Open the industry: growth distribution, money flow, network →
Who sells to whom
Customers and suppliers named in the companies' annual reports; the share is of the supplier's revenue.
- ITGR → BSX 49% of the supplier's revenue, $908M
- ITGR → ABT 10% of the supplier's revenue, $185M
- ADMT → ZOMDF
- BHE → HYPR
Growth model
Industry revenue, the same companies year on year; 80% ranges. Fitted on SEC filings and tested out of sample (how).
| Quarter | Growth Y/Y | Revenue | 80% range |
|---|---|---|---|
| Q3 2026 | +9.9% | $11.6B | $10.5B – $12.7B |
| Q4 2026 | +8.3% | $11.6B | $10.2B – $12.9B |
| Q1 2027 | +7.2% | $12.2B | $10.7B – $13.6B |
| Q2 2027 | +6.4% | $12.1B | $10.6B – $13.6B |
Capital spending and supply chain →
Companies
| Company | Quarterly revenue | Y/Y | Stage |
|---|---|---|---|
| MDT Medtronic | $9.8B | +14% | transition |
| ITGR Integer Holdings | $450M | -3% | mature |
| LIVN LivaNova | $393M | +11% | transition |
| CNMD Conmed | $336M | +0.3% | mature |
| TMDX TransMedics Group | $203M | +21% | transition |
| AXGN Axogen | $75.8M | +23% | transition |
| OM Outset Medical | $33.6M | +0.7% | mature |
| CBLL Ceribell | $29.3M | +33% | transition |
| BLFS Biolife Solutions | $28.5M | +12% | transition |
| ELMD Electromed | $19.4M | +12% | deceleration |
| IRIX Iridex | $12.6M | -7% | contraction |
| VASO Vaso | $11.2M | -44% | contraction |
| FOCL Edap TMS SA | $9.8M | +39% | expansion |
| ECOR electroCore | $9.7M | +28% | deceleration |
| POCI Precision Optics | $8.8M | +42% | deceleration |
| STXS Stereotaxis | $7.7M | -13% | transition |
| QTI QT Imaging Holdings | $7.4M | +103% | deceleration |
| HYPR Hyperfine | $3.9M | +45% | deceleration |
| ESMC Escalon Medical | $3.9M | +50% | reacceleration |
| CV CapsoVision | $3.6M | +10% | mature |
| NUWE Nuwellis | $2.0M | +14% | deceleration |
| NRXS Neuraxis | $1.9M | +116% | expansion |
| ADMT ADM Tronics Unlimited | $866K | -11% | contraction |
| POSC Positron | $112K | -7% | mature |
| NXL Nexalin Technology | $12K | -83% | contraction |
Growth from positive, comparable quarterly revenue as filed; industries are SEC Standard Industrial Classification codes. Data Nov 8, 2026.